trending Market Intelligence /marketintelligence/en/news-insights/trending/-DyEVe95TJ2WK8zPLtJnyA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Valeritas Holdings signs $21M investment deal with Aspire Capital Fund

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Valeritas Holdings signs $21M investment deal with Aspire Capital Fund

Bridgewater, N.J.-based medical technology company Valeritas Holdings Inc. said it attracted a $21 million investment in the company.

Valeritas, which is developing technologies to treat patients with type 2 diabetes in the U.S. and China, said Chicago-based investment firm Aspire Capital Fund LLC agreed to purchase $21 million worth of the company's stock over a 30-month period.

Aspire Capital has already bought 791,557 shares of the company for $1.2 million following the agreement.